Skip to main content Help with accessibility Skip to main navigation

BROLUCIZUMAB solution for injection (Beovu®▼) for neovascular (wet) age-related macular degeneration

CCG Approval Status:

Date Added: 04 - May - 2020
Body System:
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of BROLUCIZUMAB solution for injection (Beovu®▼) for neovascular (wet) age-related macular degeneration.